In addition, USP22 knockout drastically suppresses CSCs maintenance, in vivo angiogenesis, growth, and metastasis of lung cancer, and significantly sensitizes lung cancer cells including CSCs to cisplatin and irradiation [27–29]. Here, USP22 is linked to lung carcinoma.